Regulus Therapeutics Strengthens Research & Development Leadership
- Monday, June 12, 2023, 7:02
- Finance
- Add a comment
Appoints Preston S. Klassen, M.D., as President and Head of Research & Development Curtis A. Monnig, Ph.D., named Vice President of CMC SAN DIEGO, June 12, 2023 /PRNewswire/ — Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development…
About the Author
adminasapcorp has written 39579 stories on this site.